HIV drug stabilizes progression in metastatic colorectal cancer - Harvard Gazette
4/4/2022 12:00:00 AM3 yearsago
by Alice McCarthy
by Alice McCarthy
A drug widely used in HIV therapy has shown to stop disease progression in 25 percent of patients with fourth-line metastatic colorectal cancer.
A drug widely used in HIV therapy has shown to stop disease progression in 25 percent of patients with fourth-line metastatic colorectal cancer. Findings from the trial, published in Cancer Discover… [+3979 chars]
full article...